Clinical Report: Assessment of Screening Criteria and Prognosis in Lung Cancer Patients in South Korea

Overview

This study evaluates the clinical characteristics and survival outcomes of lung cancer patients in South Korea based on current screening criteria.

Background

Lung cancer is the leading cause of cancer-related mortality globally, with early detection being crucial for improving survival rates. Current screening guidelines primarily focus on high-risk groups, particularly smokers, which may overlook a substantial number of lung cancer cases, especially in regions like Asia where the epidemiology differs.

Data Highlights

No numerical data or trial data was provided in the source material.

Key Findings

• Approximately 50% of lung cancer patients in the US and UK do not meet current screening criteria.
• In Asia, the burden of lung cancer is significant, with over 60% of new cases and deaths occurring in this region.
• A growing proportion of lung cancer diagnoses in Asia are among individuals with no smoking history.
• Current screening programs in South Korea target smokers aged 54 to 74 years with a minimum of 30 pack-years of smoking history.

Clinical Implications

Healthcare providers should be aware of the limitations of current lung cancer screening criteria.

Conclusion

This study highlights the need for a reevaluation of lung cancer screening criteria.

Related Resources & Content

1. Korea National Cancer Incidence Database, 2022 -- Assessment of Screening Criteria and Prognosis in Lung Cancer Patients in South Korea
2. European Radiology — Evaluating Lung-RADS Across Various Target Populations: A Systematic Review and Meta-Analysis
3. JAMA Network Open — Cost-Effectiveness of Universal Low-Dose Computed Tomographic Lung Cancer Screening in Singapore
4. JMIR Medical Informatics — Predicting 5-Year Mortality in Non–Small-Cell Lung Cancer Using the Korean Central Cancer Registry: Model Development and Validation Study
5. The ASCO Post — Lung Nodule Program May Help Detect Cancer in Patients Age-Ineligible for Lung Cancer Screening
6. Evaluating Lung-RADS Across Various Target Populations: A Systematic Review and Meta-Analysis
7. Cost-Effectiveness of Universal Low-Dose Computed Tomographic Lung Cancer Screening in Singapore
8. Predicting 5-Year Mortality in Non–Small-Cell Lung Cancer Using the Korean Central Cancer Registry: Model Development and Validation Study
9. Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries - Sung - 2026 - CA: A Cancer Journal for Clinicians - Wiley Online Library
10. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening | New England Journal of Medicine
11. Lung cancer screening using low-dose computed tomography - NCBI Bookshelf
12. Final Recommendation Statement: Lung Cancer: Screening | United States Preventive Services Taskforce
13. Screening for lung cancer: 2023 guideline update from the American Cancer Society - Wolf - 2024 - CA: A Cancer Journal for Clinicians - Wiley Online Library
14. NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2025 - PubMed
15. Screening for Lung Cancer: CHEST Guideline and Expert Panel Report - PMC
16. National Cancer Screening Program > National Cancer Control Programs > NCCI | NATIONAL CANCER CENTER
17. 국가암검진사업 < 질병정책 < 공공보건 < 정책 : 힘이 되는 평생 친구, 보건복지부
18. 홈 >내가 알고 싶은 암>암의 종류>폐암> 폐암